Advertisement
A live webcast of the presentation can be accessed athttp://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=BSTC&item_id=2021200.
About BioSpecifics Technologies Corp.
Advertisement
BioSpecifics Technologies Corp. is a biopharmaceutical company that hasdeveloped and licensed injectable collagenase for three clinical indications:Dupuytren's disease, Peyronie's disease and frozen shoulder (adhesivecapsulitis). It has a development and licensing agreement with AuxiliumPharmaceuticals, Inc. Positive top line results from the Phase III clinicaltrials with XIAFLEX(TM) for treatment of Dupuytren's disease were released inJune 2008. More information about the company may be found on its website atwww.biospecifics.com.
SOURCE BioSpecifics Technologies Corp.